Krahasoni metodat
Shqyrtoni metodat e zgjedhura krah për krah; rreshtat që ndryshojnë janë të theksuar.
| Shkalla e Rivedhur e Ankthit dhe Depresionit të Fëmijëve× | Shkalla Shumëdimensionale e Ankthit për Fëmijë× | |
|---|---|---|
| Fusha | Psikiatria e fëmijëve | Psikiatria e fëmijëve |
| Familja | Process / pipeline | Process / pipeline |
| Viti i origjinës≠ | 2000 | 1997 |
| Krijuesi≠ | Bruce Chorpita | John March |
| Lloji | Self-report questionnaire | Self-report questionnaire |
| Burimi themelues≠ | Chorpita, B. F., Yim, L., Moffatt, C., Umemoto, A., & Francis, S. E. (2000). Assessment of symptoms of DSM-IV anxiety and depression in children: A revised child anxiety and depression scale. Behaviour Modification, 24(4), 513–537. DOI ↗ | March, J. S., Parker, J. D. A., Sullivan, K., Stallings, P., & Conners, C. K. (1997). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. Journal of the American Academy of Child & Adolescent Psychiatry, 36(4), 554–565. DOI ↗ |
| Emërtime të tjera | RCADS, RCADS-25 | MASC, MASC-2 |
| Të lidhura | 3 | 3 |
| Përmbledhja≠ | The RCADS is a 47-item (or 25-item brief version) self-report measure that assesses the full spectrum of anxiety disorders and major depression in children and adolescents ages 6–18 years. Developed by Bruce Chorpita in 2000, it provides six subscale scores aligned with DSM-IV diagnostic criteria: Separation Anxiety, Generalized Anxiety, Panic Disorder, Social Phobia, Obsessive-Compulsive Disorder, and Major Depressive Disorder. The RCADS is designed to be both a screening tool and a diagnostic aid. | The Multidimensional Anxiety Scale for Children (MASC-2) is a 39-item self-report measure of anxiety symptoms in children and adolescents ages 8–19 years. Developed by John March and colleagues in 1997, the MASC operationalizes anxiety as a multifaceted construct comprising physical symptoms, social anxiety, harm avoidance, and separation/panic concerns. The revised MASC-2 (2012) improved psychometric properties and clinical utility. It is widely used in clinical and research settings for screening, diagnosis, and outcome measurement in childhood anxiety disorders. |
| ScholarGateSeti i të dhënave ↗ |
|
|